Vai al contenuto principale della pagina
Titolo: | Allegations of waste, fraud, and abuse in pharmaceutical pricing : financial impacts on federal health programs and the federal taxpayer : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, February 9, 2007 |
Descrizione fisica: | 1 online resource (iii, 186 p.) : ill |
Soggetto topico: | Prescription pricing - Corrupt practices - United States |
Drugs - Prices - United States | |
Waste in government spending - United States | |
Soggetto non controllato: | Drugs |
Waste in government spending | |
Pricing | |
Medical | |
Political science | |
Business & economics | |
Altri titoli varianti: | Allegations of waste, fraud, and abuse in pharmaceutical pricing |
Titolo autorizzato: | Allegations of waste, fraud, and abuse in pharmaceutical pricing |
Formato: | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione: | Inglese |
Record Nr.: | 9910694354403321 |
Lo trovi qui: | Univ. Federico II |
Opac: | Controlla la disponibilità qui |